RBI Approves 2-Year Extension of ICICI Bank ED Sandeep Batra's Term

The RBI has approved the extension of ICICI Bank Executive Director Sandeep Batra's term by two years. Batra, who has been responsible for Corporate Centre since July 2018, will now serve until December 22, 2027. The approval of shareholders for the re-appointment will be sought in due course. Batra is responsible for various functions, including Corporate Communications, Finance, Human Resources, Legal, Customer Service, and Secretarial Groups. He is also responsible for risk function, internal audit, and compliance groups.

The Reserve Bank of India (RBI) has approved the extension of ICICI Bank Executive Director Sandeep Batra's term by two years. Batra, who has been responsible for the Corporate Centre since July 2018, will now serve until December 22, 2027. The approval of shareholders for the re-appointment will be sought in due course. Batra is responsible for various functions, including Corporate Communications, Finance, Human Resources, Legal, Customer Service, and Secretarial Groups. He is also responsible for risk function, internal audit, and compliance groups [1].

In addition to the extension of Batra's term, ICICI Bank has announced significant healthcare initiatives. The bank has partnered with Tata Memorial Centre (TMC) to construct a new building at the Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) in Visakhapatnam. The eight-storey, 3.9 lakh sq. ft. facility will be equipped with cutting-edge medical technology to serve 3,000 patients annually. The project is part of ICICI Bank’s ₹1,800 crore commitment to strengthen cancer care across India. The foundation stone was laid by Mr. Pradeep Kumar Sinha, Chairman, ICICI Bank, in the presence of Mr. Sandeep Batra, Executive Director, ICICI Bank, and Dr. Sudeep Gupta, Director, Tata Memorial Centre, Mumbai [2][3].

The new building, named ICICI Foundation Block for Child and Blood Cancer, will offer comprehensive treatment options, including intensive chemotherapy, bone marrow transplantation, advanced radiation therapy, cutting-edge immunotherapies like CAR-T cell therapy, high-end medical imaging and diagnostics, and 14 BMT Rooms, 14 ICUs, and 5 Operating theatres. Additionally, there will be research laboratories and joint discussion facilities for treatment planning and training [2][3].

ICICI Bank's commitment to healthcare reflects its dedication to enabling accessible and high-quality medical care for individuals in need. The bank's initiatives aim to address the growing need for cancer treatment in the region and contribute to the advancement of cancer treatment and research.

References:
[1] https://economictimes.indiatimes.com/markets/stocks/news/icici-bank-sells-18-8-stake-in-niit-institute-of-finance-banking/articleshow/121802991.cms
[2] https://www.thehindu.com/news/cities/Visakhapatnam/icici-bank-partners-with-tmc-for-new-child-and-blood-cancer-block-at-hbchrc/article69687054.ece
[3] https://www.deccanchronicle.com/southern-states/andhra-pradesh/icici-bank-tmc-lay-foundation-for-550-cr-cancer-block-in-vizag-1884942